EuropaBio asserts its strengths in healthcare sector
This article was originally published in Clinica
Executive Summary
The new chairman of the European association of bioindustries, EuropaBio, Hans Kast, has called for "a clear legal framework in support of biotechnology in Europe". The president and CEO of BASF Plant Science made the comments in his acceptance speech at the association's AGM on June 2. He takes on his new role just as 19 new corporate members join EuropaBio, mainly from the healthcare and pharmaceutical sectors, bringing the total direct company membership to over 50.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.